Article
Recurrent <i>FBXW7</i> mutations bypass Wnt/β-catenin addiction in cancer
2023-07-29
Abstract excerpt
Pathologic Wnt/β-catenin signaling drives various cancers, leading to multiple approaches to drug this pathway. Appropriate patient selection can maximize success of these interventions. Wnt ligand addiction is a druggable vulnerability in RNF43 -mutant/ RSPO -fusion cancers. However, pharmacologically targeting the biogenesis of Wnt ligands, e.g., with PORCN inhibitors, has shown mixed therapeutic responses, po...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8fb7706b-18c4-5ff5-8a31-5d34947d965f
- DOI
- 10.1101/2023.07.28.550933
